Overview

Pregabalin for Alcohol Dependence

Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is: Pregabalin is superior to placebo in preventing relapse to drinking and reducing drinking severity
Phase:
Phase 4
Details
Lead Sponsor:
St. Petersburg Bekhterev Research Psychoneurological Institute
Collaborator:
St.-Petersburg Bekhterev Research Psychoneurological Institute, Russian Federation
Treatments:
Pregabalin